Zoledronic acid, also known as zoledronate, is a medication used to treat a number of bone diseases. These include osteoporosis, high blood calcium due to cancer, bone breakdown due to cancer, and Paget's disease of bone. It is given by injection into a vein.
This report contains market size and forecasts of Zoledronic Acid in global, including the following market information:
Global Zoledronic Acid Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Zoledronic Acid Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Zoledronic Acid companies in 2021 (%)
The global Zoledronic Acid market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Injection Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Zoledronic Acid include Mylan, Eli Lilly, Pfizer, Apotex, Teva, Amgen, Tecoland, Novartis and Emcure Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Zoledronic Acid manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Zoledronic Acid Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Zoledronic Acid Market Segment Percentages, by Type, 2021 (%)
Injection
Powder
Global Zoledronic Acid Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Zoledronic Acid Market Segment Percentages, by Application, 2021 (%)
Metastatic Bone Cancers
Systemic Metabolic Bone Diseases
Global Zoledronic Acid Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Zoledronic Acid Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Zoledronic Acid revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Zoledronic Acid revenues share in global market, 2021 (%)
Key companies Zoledronic Acid sales in global market, 2017-2022 (Estimated), (MT)
Key companies Zoledronic Acid sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Mylan
Eli Lilly
Pfizer
Apotex
Teva
Amgen
Tecoland
Novartis
Emcure Pharma
Taj Pharmaceuticals
Natco Pharma
Scinopharm Taiwan
Lianyungang Runzhong Pharmaceutical
Hangzhou Longshine Bio-Tech